Macrophage migration inhibitory factor (MIF) and miR-301b interactively enhance disease aggressiveness by targeting NR3C2 in human pancreatic cancer

被引：1

作者：

Yang, Shouhui ^{[1
]}

He, Peijun ^{[1
]}

Wang, Jian ^{[1
]}

Schetter, Aaron ^{[2
]}

Funamizu, Naotake ^{[3
]}

Yanaga, Katsuhiko ^{[3
]}

Gaedcke, Jochen ^{[4
]}

Ghadimi, B. Michael ^{[4
]}

Gaida, Matthias M. ^{[5
]}

Ried, Thomas ^{[6
]}

Hanna, Nader ^{[7
]}

Alexander, H. Richard ^{[7
]}

Hussain, S. Perwez ^{[1
]}

机构：

[1] NCI, Pancreat Canc Unit, Human Carcinogenesis Lab, CCR, Bethesda, MD 20892 USA

[2] NCI, Human Carcinogenesis Lab, CCR, Bethesda, MD 20892 USA

[3] Jikei Univ, Sch Med, Dept Surg, Tokyo, Japan

[4] Univ Med, Dept Gen & Visceral Surg, Gottingen, Germany

[5] NCI, Lab Immune Cell Biol, CCR, Bethesda, MD 20892 USA

[6] NCI, Genet Branch, CCR, Bethesda, MD 20892 USA

[7] Univ Maryland, Sch Med, Div Surg Oncol, Baltimore, MD 21201 USA

来源：

关键词：

D O I：

10.1158/1538-7445.AM2014-4363

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

4363

引用

页数：1